AT1 – Atomo Diagnostics Ltd


Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month


1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Atomo Diagnostics Limited is an Australia-based medical device company engaged in the development and sale of medical devices. The Company’s AtomoRapid is offering rapid diagnostic test (RDT) platform, which simplify procedures, mitigate common user errors and enhance test performance. The Company’s technology platforms include AtomoRapid Elion, AtomoRapid Galileo, AtomoRapid Pascal, AtomoRapid Da Vinci and AtomoRapid Franklin. The Company’s products portfolio includes COVID-19 Test, Human Immunodeficiency Virus (HIV)1&2 Test, Pregnancy Test and Respiratory Test. The Company offers an antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus, as well as an antibody test to indicate if a user has protection from the virus. Respiratory Test develops a novel, rapid, point-of-care test that differentiates between viral versus bacterial acute respiratory infection.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan